All of our COVID-19 tests are designated with FDA Emergency Use Authorization (EUA).

Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation's public health protections against threats by facilitating the availability and use of Medical Countermeasures (MCMs) needed during public health emergencies. Valid COVID-19 tests are required to have either FDA approval, or at least FDA EUA classifications to be used. 

You will receive the results same-day. You will receive your results after the pharmacy documents the test appropriately.

Tarrytown Pharmacy utilizes a RAPID point-of-care test, which means that results are MUCH quicker to receive back.

The specimen is collected and tested at the "point-of-care" which means that it does not need to be shipped to a laboratory to be processed. The specimen is able to be analyzed at Tarrytown Pharmacy, and results will be received extremely quickly.

Our COVID-19 tests are CLIA-wavied tests approved for point-of-care use in pharmacies.

CLIA stands for "Clinical Laboratory Improvement Amendments of 1988" and required stringent standards for certain types of human specimen tests for health assessment or the diagnosis, prevention, or treatment of disease. 

CLIA-waived tests include tests cleared by the FDA for home use and those approved for waiver under the CLIA criteria. Although CLIA requires that waived tests must be simple and have a low risk for erroneous results, this does not mean that waived tests are completely error-proof. To decrease the risk of erroneous results, the test needs to be performed correctly, by trained personnel  (Tarrytown Pharmacists).